2Ruilope LM,.Jakobsen A,Heroys J,et al. Prospects for renovascular protection by more aggressive renin-angiotensin system control [J].Medscape J Med,2008,26 (10 Suppl):S5.
3Pepine C J,Handberg EM,Cooper-DeHoff RM,et al.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease.The International Verapamil-Trandolapril Study (INVEST):a randomized controlled trial.JAMA,2003,290:2805-2816.
4Weber MA,Julius S,Kjeldsen SE,et al.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.Lancet,2004,363:2049-2051.
5Mourad JJ,Waeber B,Zannad F,et al.Comparison of different therapeutic strategies in hypertension:a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.J Hypertens,2004,22:2379-2386.
6Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):a multicentre randomised controlled trial.Lancet,2005,366:895-906.
7Pickkers P,Garcha RS,Schachter M,et al.Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide.Hypertension,1999,33:1043-1048.
8Sturkenboom M,Picelli G,Dieleman JP,et al.Patient adherence and persistence with antihypertensive therapy:one-versus two-pill combination.Presented at the 15th European Meeting on Hypertension,Milan,Italy,June 17-21,2005.
